Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Vall d'Hebron Institute of Oncology | Researchclopedia

Back to institutions

Vall d'Hebron Institute of Oncology

Barcelona, Cataloniahealthcare

5,651

Works

511,290

Citations

323

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics Lung Cancer Treatments and Mutations

Top Researchers

Charles M. Perou University of North Carolina at Chapel Hill

2,024 works250,357 citationsh-index: 193

Recent Research

Blockade of the KRAS-FOSL1 axis elicits DNA damage repair deficiency exploitable with local and systemic genotoxic therapies

S. Vicent,Connor Welch,et al.

20260 citations

Colorectal Cancer Treatments and Studies

HER2/EGFR in Cancer Research

Advanced Breast Cancer Therapies

Cancer Treatment and Pharmacology

PARP inhibition in cancer therapy

Lung Cancer Research Studies

CAR-T cell therapy research

Pancreatic and Hepatic Oncology Research

Genetic factors in colorectal cancer

Jörge E. Cortes Augusta University Health

3,571 works143,300 citationsh-index: 179

Gabriel N. Hortobágyi The University of Texas MD Anderson Cancer Center

1,905 works139,590 citationsh-index: 187

David Cunningham Oldham Council

2,057 works130,386 citationsh-index: 153

Carlos Caldas Universidade Federal do Rio de Janeiro

1,380 works128,262 citationsh-index: 158

Josep Tabernero Hebron University

2,703 works126,607 citationsh-index: 146

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching

Majd Abdallah,Sigve Nakken,et al.

20260 citations

113P Translational analysis of acasunlimab in combination with pembrolizumab in CPI-treated metastatic NSCLC

B. Besse,P. Garrido Castro,et al.

20260 citations

565eP Gender differences in quality of life, mental health, and survivorship experiences following lung cancer: A systematic literature review

N. Florez,Cecilia Pompili,et al.

20260 citations

LBA1 Ceralasertib (C) + durvalumab (D) in patients (pts) with locally advanced (LA) or metastatic (m) NSCLC who progressed on or after anti-PD-(L)1 and platinum-based chemotherapy (CT): Results from LATIFY

B. Besse,E. Felip,et al.

20260 citations

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer

Paolo Tarantino,Se-Eun Kim,et al.

20260 citations